Commercial Intravenous Immunoglobulin Preparations Contain Functional Neutralizing Antibodies against the Staphylococcus aureus Leukocidin LukAB (LukGH).

Authors

James B Wood
Lauren S Jones DO, Lehigh Valley Health NetworkFollow
Nicole R Soper
Meera Nagarsheth
C Buddy Creech
Isaac P Thomsen

Publication/Presentation Date

11-1-2017

Abstract

The pathogenesis of

Volume

61

Issue

11

ISSN

1098-6596

Published In/Presented At

Wood, J. B., Jones, L. S., Soper, N. R., Nagarsheth, M., Creech, C. B., & Thomsen, I. P. (2017). Commercial Intravenous Immunoglobulin Preparations Contain Functional Neutralizing Antibodies against the Staphylococcus aureus Leukocidin LukAB (LukGH). Antimicrobial agents and chemotherapy, 61(11), e00968-17. https://doi.org/10.1128/AAC.00968-17

Disciplines

Medicine and Health Sciences

PubMedID

28874371

Department(s)

Fellows and Residents

Document Type

Article